| Bifidobacterium animalis subsp. lactis BB-12 |
Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. ↗ |
|
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients. ↗
|
| Understanding the probiotic health benefits of Bifidobacterium animalis subsp. lactis, BB-12™. ↗ |
| Bifidobacterium animalis subsp. lactis HN019 |
Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. ↗ |
| Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional issues. ↗ |
| Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. ↗ |
| Lactobacillus plantarum YS4 |
SCI: https://doi.org/10.3390/app8030363 ↗
https://doi.org/10.1155/2020/9048971. ↗
植物乳杆菌YS4及其在制备预防便秘的食品中的应用. ↗
|
| Preventive Effects of YS4 on Constipation Induced by Activated Carbon in Mice. ↗ |
| Lactobacillus johnsonii LJ10 |
Postbiotics From Lactobacillus johnsonii Activates Gut Innate Immunity to Mitigate Alcohol-Associated Liver Disease. ↗ |
| Lactobacillus salivarius LS01 |
Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. ↗ |
